Arch Biopartners (TSXV:ARCH) Operating Cash Flow per Share : C$-0.03 (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Operating Cash Flow per Share?

Arch Biopartners's operating cash flow per share for the three months ended in Dec. 2023 was C$-0.01. Arch Biopartners's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was C$-0.03.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Arch Biopartners was -680.00% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 50.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Arch Biopartners's Operating Cash Flow per Share or its related term are showing as below:

TSXV:ARCH' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -61.6 Med: 8.05 Max: 68.4
Current: 50

During the past 13 years, Arch Biopartners's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.40% per year. The lowest was -61.60% per year. And the median was 8.05% per year.

TSXV:ARCH's 3-Year OCF Growth Rate is ranked better than
91.41% of 1234 companies
in the Biotechnology industry
Industry Median: 3.5 vs TSXV:ARCH: 50.00

Arch Biopartners Operating Cash Flow per Share Historical Data

The historical data trend for Arch Biopartners's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Operating Cash Flow per Share Chart

Arch Biopartners Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.03

-0.05

0.01

Arch Biopartners Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-0.01	-0.02	0.01	-0.01	-0.01

Competitive Comparison of Arch Biopartners's Operating Cash Flow per Share

For the Biotechnology subindustry, Arch Biopartners's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Price-to-Operating-Cash-Flow falls into.

Arch Biopartners Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Arch Biopartners's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )	=	Cash Flow from Operations (A: Sep. 2023 )	/	Shares Outstanding (Diluted Average) (A: Sep. 2023 )
	=	-0.234	/	62.466
	=	-0.00

Arch Biopartners's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-0.546	/	62.466
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03

Arch Biopartners Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.